Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Projected Valuation Of The In Vivo Toxicology Market In The Coming Years?

The market for in-vivo toxicology has seen significant growth in the past few years. The sector, estimated to be worth $5.24 billion in 2024, is projected to rise to $5.61 billion in 2025, recording a compound annual growth rate (CAGR) of 7.1%. Factors such as the growing necessity for studies that adhere to Good Laboratory Practice (GLP), an increase in REACH regulations, expansion in biologics, and biosimilars requiring safety assessments, as well as increased investment in the development of oncology drugs and the expansion of gene and cell therapy pipelines, have contributed to the historical growth period.

Expectations are high for the in-vivo toxicology market to significantly expand in the coming years, with projections of it reaching $7.31 billion by 2029 – exhibiting a compound annual growth rate (CAGR) of 6.8%. Various contributing factors to this forecasted growth include an upswing in global drug development efforts, a rising requirement for personalized medicine, an increase in the volume of clinical trials, as well as escalating outsourcing of toxicology testing from pharmaceutical companies. There is also heightening consumer safety awareness regarding food and personal care products. Specific trends to watch for during this predicted growth period are advances in animal models, integration of imaging technology into in vivo studies, the rise of automated data collection systems, incorporation of AI and ML into toxicology data analysis, and new developments in animal telemetry and biomarker detection.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25791&type=smp

Which Growth Drivers Are Shaping The In Vivo Toxicology Market Outlook?

The surge in drug discoveries is set to fuel the expansion of the in vivo toxicology market. The process of drug discovery entails identifying and designing new substances that can act as remedies or preventatives for diverse diseases. Advances in biotechnology have played a significant role in accelerating this process by improving our grasp of how diseases function, thereby facilitating the development of more precise treatments. In vivo toxicology plays a crucial role in drug discovery as it allows for the assessment of safety, tolerability, and potential negative effects of experimental compounds in whole organisms. Furthermore, it assists in determining dose-limiting toxicities and dictates formulation and dosing methods before clinical advancements. For example, the Government of Canada reported in May 2025 that the worldwide number of medicines in clinical development had grown to 10,134 as of March 2025, reflecting a 20% increase since September 2021. Consequently, the escalating number of drug discoveries is pushing the in vivo toxicology market’s growth.

What Is The Segment Breakdown Of The In Vivo Toxicology Market?

The in vivo toxicology market covered in this report is segmented –

1) By Product: Consumables, Instruments

2) By Testing Types: Chronic Toxicity Testing, Sub-Chronic Toxicity Testing, Sub-Acute Toxicity Testing, Acute Toxicity Testing

3) By Methodology: In Vivo Animal Models, Genetically Modified Organisms, Non-Human Primate Studies, Rodent Models, Larger Mammals

4) By Application: Immunotoxicity, Systemic Toxicity, Carcinogenicity, Genotoxicity, Developmental And Reproductive Toxicity (DART), Other Applications

5) By End-User: Pharmaceutical Companies, Biosimilars Manufacturers, Contract Research Organizations (CROs), Academic And Research Institutions, Biotechnology Firms

Subsegments:

1) By Consumables: Animal Models, Reagents And Kits, Assay Kits, Toxicology Testing Media, Antibodies, Biochemicals, Buffers And Solutions, Disposable Labware, Animal Feed, Diluents

2) By Instruments: Imaging Systems, Flow Cytometers, PCR Machines, Spectrophotometers, Microscopes, Analyzers, Centrifuges, Incubators, Animal Monitoring Systems, Automated Liquid Handling Systems

How Are Global Trends Impacting The Development Of The In Vivo Toxicology Market?

Leading firms in the in vivo toxicology market are concentrating their efforts on creating advanced solutions including secure cloud-based real-time data platforms that enhance study management and accelerate decision-making processes. These platforms give researchers and clients the ability to access key information related to toxicology studies, timelines, planning tools, and important documents remotely and securely, fostering improved collaboration and transparency. For example, in March 2023, Charles River Laboratories International Inc., a major U.S. contract research company, introduced Apollo, a secure, cloud-based platform specifically designed to offer real-time access to toxicology study data. The platform, equipped with data visualization tools and milestone tracking, supports general in vivo toxicology studies and enables faster, better-informed decision-making by offering immediate access to crucial study data. Additionally, Apollo aids in the streamlining of project planning and budget estimation throughout the drug development cycle. Through the digitization of toxicology workflows, Apollo increases accuracy, efficiency, and teamwork in in vivo research.

Who Are The Major Stakeholders Operating In The In Vivo Toxicology Market?

Major companies operating in the in vivo toxicology market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (Labcorp), Sigma-Aldrich Co. LLC, Eurofins Scientific SE, SGS Société Générale de Surveillance SA, Agilent Technologies Inc., WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Jubilant Life Sciences Limited, Evotec SE, The Jackson Laboratory, Inotiv Inc., SRI International, MatTek Corporation, Transcure Bioservices Pvt. Ltd., Altogen Labs.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/in-vivo-toxicology-global-market-report

Which Region Is Likely To Register The Fastest Growth In The In Vivo Toxicology Market?

North America was the largest region in the in-vivo toxicology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vivo toxicology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=25791&type=smp

Browse Through More Reports Similar to the Global In Vivo Toxicology Market 2025, By The Business Research Company

Cytotoxic Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cytotoxic-drugs-global-market-report

In Vitro Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report

Cell Viability Assays Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

About The Business Research Company:

With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model